<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-11-18965</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0034460</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Computational biology</subject>
          </subj-group>
          <subj-group>
            <subject>Microbiology</subject>
            <subj-group>
              <subject>Virology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Computer science</subject>
          <subj-group>
            <subject>Algorithms</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Gastroenterology and hepatology</subject>
            <subj-group>
              <subject>Liver diseases</subject>
              <subj-group>
                <subject>Infectious hepatitis</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Infectious diseases</subject>
            <subj-group>
              <subject>Viral diseases</subject>
              <subj-group>
                <subject>Hepatitis</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Oncology</subject>
            <subj-group>
              <subject>Cancers and neoplasms</subject>
              <subj-group>
                <subject>Gastrointestinal tumors</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Virology</subject>
          <subject>Infectious Diseases</subject>
          <subject>Computational Biology</subject>
          <subject>Oncology</subject>
          <subject>Computer Science</subject>
          <subject>Gastroenterology and Hepatology</subject>
        </subj-group>
      </article-categories><title-group><article-title>Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma</article-title><alt-title alt-title-type="running-head">Classification of Liver Cirrhosis and Cancer</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Huang</surname>
            <given-names>Tao</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Junjie</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">
            <sup>9</sup>
          </xref>
          <xref ref-type="aff" rid="aff10">
            <sup>10</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Cai</surname>
            <given-names>Yu-Dong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <xref ref-type="aff" rid="aff14">
            <sup>14</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Yu</surname>
            <given-names>Hanry</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
          <xref ref-type="aff" rid="aff8">
            <sup>8</sup>
          </xref>
          <xref ref-type="aff" rid="aff9">
            <sup>9</sup>
          </xref>
          <xref ref-type="aff" rid="aff10">
            <sup>10</sup>
          </xref>
          <xref ref-type="aff" rid="aff11">
            <sup>11</sup>
          </xref>
          <xref ref-type="aff" rid="aff12">
            <sup>12</sup>
          </xref>
          <xref ref-type="aff" rid="aff13">
            <sup>13</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Chou</surname>
            <given-names>Kuo-Chen</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
            <sup>14</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Systems Biology, Shanghai University, Shanghai, People's Republic of China</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Shanghai Center for Bioinformation Technology, Shanghai, People's Republic of China</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Graduate School of the Chinese Academy of Sciences, Beijing, People's Republic of China</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Centre for Computational Systems Biology, Fudan University, Shanghai, People's Republic of China</addr-line>       </aff><aff id="aff6"><label>6</label><addr-line>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore</addr-line>       </aff><aff id="aff7"><label>7</label><addr-line>Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore</addr-line>       </aff><aff id="aff8"><label>8</label><addr-line>NUS Graduate School for Integrative Sciences and Engineering, Centre for Life Sciences, Singapore, Singapore</addr-line>       </aff><aff id="aff9"><label>9</label><addr-line>Mechanobiology Institute of Singapore, Temasek Laboratories, National University of Singapore, Singapore, Singapore</addr-line>       </aff><aff id="aff10"><label>10</label><addr-line>Singapore-MIT Alliance, Computational and System Biology Program, Singapore, Singapore</addr-line>       </aff><aff id="aff11"><label>11</label><addr-line>NUS Tissue Engineering Program, DSO Labs, National University of Singapore, Singapore, Singapore</addr-line>       </aff><aff id="aff12"><label>12</label><addr-line>Singapore-MIT Alliance for Research and Technology, Singapore, Singapore</addr-line>       </aff><aff id="aff13"><label>13</label><addr-line>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line>       </aff><aff id="aff14"><label>14</label><addr-line>Gordon Life Science Institute, San Diego, California, United States of America</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Tavis</surname>
            <given-names>John E.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Saint Louis University, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">cai_yud@yahoo.com.cn</email> (YDC); <email xlink:type="simple">hanry_yu@nuhs.edu.sg</email> (HY); <email xlink:type="simple">kcchou@gordonlifescience.org</email> (KCC)</corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: YDC HY. Performed the experiments: TH. Analyzed the data: TH KCC. Contributed reagents/materials/analysis tools: JW. Wrote the paper: TH JW HY KCC.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>6</day>
        <month>4</month>
        <year>2012</year>
      </pub-date><volume>7</volume><issue>4</issue><elocation-id>e34460</elocation-id><history>
        <date date-type="received">
          <day>27</day>
          <month>9</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2012</copyright-year><copyright-holder>Huang et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>Hepatitis C virus (HCV) is a main risk factor for liver cirrhosis and hepatocellular carcinoma, particularly to those patients with chronic liver disease or injury. The similar etiology leads to a high correlation of the patients suffering from the disease of liver cirrhosis with those suffering from the disease of hepatocellular carcinoma. However, the biological mechanism for the relationship between these two kinds of diseases is not clear. The present study was initiated in an attempt to investigate into the HCV infection protein network, in hopes to find good biomarkers for diagnosing the two diseases as well as gain insights into their progression mechanisms. To realize this, two potential biomarker pools were defined: (i) the target genes of HCV, and (ii) the between genes on the shortest paths among the target genes of HCV. Meanwhile, a predictor was developed for identifying the liver tissue samples among the following three categories: (i) normal, (ii) cirrhosis, and (iii) hepatocellular carcinoma. Interestingly, it was observed that the identification accuracy was higher with the tissue samples defined by extracting the features from the second biomarker pool than that with the samples defined based on the first biomarker pool. The identification accuracy by the jackknife validation for the between-genes approach was 0.960, indicating that the novel approach holds a quite promising potential in helping find effective biomarkers for diagnosing the liver cirrhosis disease and the hepatocellular carcinoma disease. It may also provide useful insights for in-depth study of the biological mechanisms of HCV-induced cirrhosis and hepatocellular carcinoma.</p>
      </abstract><funding-group><funding-statement>This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087) to YDC and the Institute of Bioengineering and Nanotechnology, Jassen Cilag Grant(R-185-000-182-592), Singapore-MIT Alliance Computational and Systems Biology Flagship Project (C-382-641-001-091), SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore (R-714-001-003-271) to HY. JW is SMA (Singapore-MIT Alliance) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="9"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Hepatitis C virus (HCV) is an important risk factor for liver cirrhosis and hepatocellular carcinoma <xref ref-type="bibr" rid="pone.0034460-Tsukuma1">[1]</xref>, <xref ref-type="bibr" rid="pone.0034460-ElSerag1">[2]</xref>, <xref ref-type="bibr" rid="pone.0034460-Tagger1">[3]</xref>, <xref ref-type="bibr" rid="pone.0034460-Farazi1">[4]</xref>. The pathogenesis of these diseases is a multi-step process, including hepatocellular damage and apoptosis, wound-healing responses, inflammatory responses, and hepatocellular regeneration <xref ref-type="bibr" rid="pone.0034460-DeGiorgi1">[5]</xref>. It is also well known that liver cirrhosis has high potential to lead to hepatocellular carcinoma, especially in the case of HCV-induced cirrhosis <xref ref-type="bibr" rid="pone.0034460-ElSerag2">[6]</xref>. Thus, these two diseases are often correlated with each other, and diagnosis of cirrhosis and HCC at early stages remains challenging <xref ref-type="bibr" rid="pone.0034460-Hoshida1">[7]</xref>. The detailed mechanisms of HCV-induced cirrhosis and hepatocellular carcinoma are unknown <xref ref-type="bibr" rid="pone.0034460-Farazi1">[4]</xref>. Rapid detection of liver cirrhosis or hepatocellular carcinoma will help provide a timely and appropriate treatment so as to enhance the survival rate of the patient <xref ref-type="bibr" rid="pone.0034460-Shang1">[8]</xref>, <xref ref-type="bibr" rid="pone.0034460-Zhang1">[9]</xref>. Understanding of the detailed mechanisms of disease progression can help in developing therapeutic strategies. For example, after revealing the roles of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor signaling in hepatocellular carcinoma, their inhibitor Brivanib provides a novel therapeutic treatment against hepatocellular carcinoma <xref ref-type="bibr" rid="pone.0034460-Kudo1">[10]</xref>. To find effective diagnosis methods for cirrhosis and hepatocellular carcinoma and reveal their mechanisms, knowledge of large-scale HCV infection networks from high-throughput experimental techniques is very useful <xref ref-type="bibr" rid="pone.0034460-Lemmer1">[11]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wang1">[12]</xref>, <xref ref-type="bibr" rid="pone.0034460-Zhang2">[13]</xref>. In the traditional biomarker studies, the selected biomarkers were often quite different for different studies, and only had a very small overlap <xref ref-type="bibr" rid="pone.0034460-Michiels1">[14]</xref>, <xref ref-type="bibr" rid="pone.0034460-Abraham1">[15]</xref>. Since there was little concordance among the reported markers, it was hard to identify high-quality biomarkers.</p>
      <p>In our approach, we defined two potential biomarker pools, which we will refer to as the “target genes” and “between genes”. The target genes were the human genes associated with the HCV proteins. The between genes were the human genes that were on the shortest paths between the target genes in the protein interaction network. Such two sets of genes have strong biological rationales in correlation with the risk factors that cause liver cirrhosis and hepatocellular carcinoma. Utilizing the concrete HCV-human interaction information would help to exclude the false positive markers. Selecting biomarkers from the target genes and the between-genes would not only make them have an intrinsic correlation with liver cirrhosis and hepatocellular carcinoma diagnosis, but also provide useful information for HCV-induced liver transformation. Indeed, we found that the information of the between-genes among the target genes of HCV can be used to better classify the liver cirrhosis and hepatocellular carcinoma samples than the target genes of HCV. These findings suggest that the interactions between the target genes of HCV are more important than the target genes themselves in triggering liver cirrhosis and hepatocellular carcinoma. It was observed by examining the selected biomarkers that some meaningful correlations did exist among liver cirrhosis, hepatocellular carcinoma, and the genes involved in other cellular processes. The biomarkers found in this study may be of use for diagnosing HCV-induced cirrhosis and hepatocellular carcinoma, as well as for revealing their pathogenic mechanisms.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <p>According a recent review <xref ref-type="bibr" rid="pone.0034460-Chou1">[16]</xref>, to develop a useful model or predictor for biological systems, the following procedures were usually needed to consider: (i) benchmark dataset construction or selection; (ii) mathematical formulation for biological samples that can truly reflect their intrinsic correlation with the target to be predicted; (iii) introducing or developing a powerful algorithm (or engine) to operate the prediction; (iv) properly performing cross-validation tests to objectively evaluate the anticipated accuracy of the predictor. Below, let us elaborate how to deal with these procedures.</p>
      <sec id="s2a">
        <title>Benchmark dataset: gene expression profiles of normal, cirrhotic, and carcinoma liver tissues</title>
        <p>The benchmark dataset used in this study contained 124 tissue samples, of which 19 samples were from normal persons, 58 from the cirrhotic patients, and 47 from the hepatocellular carcinoma patients. The corresponding gene expression profiles for the 19 normal, 58 cirrhotic, and 47 hepatocellular carcinoma (HCC) liver tissue samples were from Mas's work <xref ref-type="bibr" rid="pone.0034460-Mas1">[17]</xref> at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE14323" xlink:type="simple">http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE14323</ext-link>. The data from the two Affymetrix platforms, HG-U133A and HG-U133A 2.0, were combined by means of the R package matchprobes <xref ref-type="bibr" rid="pone.0034460-Huber1">[18]</xref>. The Robust Multi-Array (RMA) method was utilized to process the data <xref ref-type="bibr" rid="pone.0034460-Irizarry1">[19]</xref>. Duplicated probes for each gene were averaged and the processed data were normalized with the quantile method <xref ref-type="bibr" rid="pone.0034460-Bolstad1">[20]</xref>. There were a total of 12,936 genes, and their expression levels were measured in the 124 samples. According to the set theory, the benchmark dataset <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e001" xlink:type="simple"/></inline-formula> can be formulated as<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e002" xlink:type="simple"/><label>(1)</label></disp-formula>where the subset <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e003" xlink:type="simple"/></inline-formula> contains 19 normal liver tissue samples, subset <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e004" xlink:type="simple"/></inline-formula> contains 58 cirrhotic liver tissue samples, subset <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e005" xlink:type="simple"/></inline-formula> contains 47 hepatocellular carcinoma liver tissue samples, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e006" xlink:type="simple"/></inline-formula> represents the symbol for “union”.</p>
      </sec>
      <sec id="s2b">
        <title>Tissue sample representation</title>
        <p>To develop a powerful statistical prediction method for identifying the attributes of biological samples, one of the most important steps is to extract the core and essential features of the samples that are closely correlated with the target to be identified <xref ref-type="bibr" rid="pone.0034460-Chou2">[21]</xref>. According to Eq. 6 of <xref ref-type="bibr" rid="pone.0034460-Chou1">[16]</xref>, the representation of a tissue sample, or its feature vector, can be formulated as<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e007" xlink:type="simple"/><label>(2)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e008" xlink:type="simple"/></inline-formula> represents the tissue sample, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e009" xlink:type="simple"/></inline-formula> the transpose operator, the components <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e010" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e011" xlink:type="simple"/></inline-formula>, … and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e012" xlink:type="simple"/></inline-formula> will depend on how to extract the desired information from the tissue sample, as will be elaborated below.</p>
      </sec>
      <sec id="s2c">
        <title>Hepatitis C virus network</title>
        <p>In de Chassey et al.'s study, they identified 481 interactions between HCV and human proteins by the yeast two-hybrid experiments and literature mining <xref ref-type="bibr" rid="pone.0034460-deChassey1">[22]</xref>. Here, we used the interactions identified by them to construct the hepatitis C virus – human network. The human-protein interaction networks we used were downloaded from STRING <xref ref-type="bibr" rid="pone.0034460-Jensen1">[23]</xref>. STRING is a comprehensive protein-protein interaction network and the interactions in STRING include physical and functional associations between proteins derived from previous knowledge, genomic context, conserved coexpression and high-throughput experiments <xref ref-type="bibr" rid="pone.0034460-Jensen1">[23]</xref>. The weight of STRING network was defined as one minus the confidence score.</p>
      </sec>
      <sec id="s2d">
        <title>The target genes of HCV and the between genes among target genes of HCV</title>
        <p>We defined two potential biomarker pools that have strong biological rationales associated with the culprits of the liver cirrhosis and hepatocellular carcinoma: (i) the target genes, and (ii) the between-genes. <xref ref-type="fig" rid="pone-0034460-g001">Figure 1</xref> shows the relationship among the HCV proteins, target genes and the between genes. The target genes were the human target genes of the HCV proteins. The between genes were the human genes that were on the shortest paths between the target genes in the STRING network.</p>
        <fig id="pone-0034460-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0034460.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>The relationship among the HCV proteins, the target genes and the between genes.</title>
            <p>The yellow node (V1, V2) are HCV proteins. The target genes (blue nodes, T1, T2 and T3) were the human target genes of HCV proteins. The between genes (red nodes, B1, B2 and B3) were human genes that were on the shortest paths between target genes in protein interaction network. The grey nodes were other human proteins that were neither target genes, nor between genes.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.g001" xlink:type="simple"/>
        </fig>
        <p>There were 290 target genes associated with the 10 HCV proteins that were measured in our dataset and can be mapped onto the STRING network.</p>
        <p>To obtain the between-genes among the target genes of HCV, we linked each pair of the target genes of the 10 HCV proteins by searching the shortest paths between them. The technique we used to find the shortest path was Dijkstra's algorithm <xref ref-type="bibr" rid="pone.0034460-Dijkstra1">[24]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chartrand1">[25]</xref>, <xref ref-type="bibr" rid="pone.0034460-Cormen1">[26]</xref>. The genes on the shortest paths between the target genes of HCV were defined as the between-genes among the target genes of HCV. There were 684 between-genes among the target genes of HCV.</p>
        <p>Accordingly, if using the features of the target genes to represent the tissue samples, Eq. 2 will become a vector with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e013" xlink:type="simple"/></inline-formula> components; i.e.,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e014" xlink:type="simple"/><label>(3)</label></disp-formula>If using the features of the between genes to represent the tissue samples, Eq. 2 will become a vector with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e015" xlink:type="simple"/></inline-formula> components; i.e.,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e016" xlink:type="simple"/><label>(4)</label></disp-formula></p>
      </sec>
      <sec id="s2e">
        <title>Minimum Redundancy Maximum Relevance (mRMR)</title>
        <p>In this study, we used the mRMR (Minimum Redundancy Maximum Relevance) approach <xref ref-type="bibr" rid="pone.0034460-Peng1">[27]</xref> to select the genes that can be used for classification of liver cirrhosis and hepatocellular carcinoma from the 290 target genes and the 684 between genes, respectively. The advantage of using the mRMR method here is that it can balance the minimum redundancy and the maximum relevance. The maximum relevance would guarantee selecting those features with the most contributions to the classification, while the minimum redundancy would guarantee excluding those features that had already been covered by the selected features. During the selecting process, one feature at a time was selected by mRMR into the selected list. In each round, a feature with the maximum relevance and minimum redundancy was selected. As a result, we obtained an ordered list of features. The mRMR program is available at <ext-link ext-link-type="uri" xlink:href="http://penglab.janelia.org/proj/mRMR/" xlink:type="simple">http://penglab.janelia.org/proj/mRMR/</ext-link>.</p>
      </sec>
      <sec id="s2f">
        <title>Nearest neighbor algorithm</title>
        <p>In this study, the nearest neighbor algorithm (NNA) <xref ref-type="bibr" rid="pone.0034460-Cover1">[28]</xref>, <xref ref-type="bibr" rid="pone.0034460-Friedman1">[29]</xref>, <xref ref-type="bibr" rid="pone.0034460-Denoeux1">[30]</xref> was used as a prediction engine to identify sample classes as implemented in the NNA program (available at <ext-link ext-link-type="uri" xlink:href="http://pcal.biosino.org/NNA.html" xlink:type="simple">http://pcal.biosino.org/NNA.html</ext-link>). Owing to its good performance and simple-to-use feature, the NNA classifier is quite popular in pattern recognition and has been widely used to deal with varieties of biological problems (see, e.g., <xref ref-type="bibr" rid="pone.0034460-Chou3">[31]</xref>, <xref ref-type="bibr" rid="pone.0034460-Hu1">[32]</xref>, <xref ref-type="bibr" rid="pone.0034460-Hu2">[33]</xref>, <xref ref-type="bibr" rid="pone.0034460-Huang1">[34]</xref>, <xref ref-type="bibr" rid="pone.0034460-Huang2">[35]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wang2">[36]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chou4">[37]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wu1">[38]</xref>, <xref ref-type="bibr" rid="pone.0034460-Xiao1">[39]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wang3">[40]</xref>, <xref ref-type="bibr" rid="pone.0034460-Xiao2">[41]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chou5">[42]</xref>). According to the NNA rule, the query sample should be assigned to the same class as the one in the training dataset that is nearest to the query sample. In case there are two or more samples in the training dataset that have exactly the same closest distance to the query sample, then the query sample will be randomly assigned to any one of their classes although this kind of case rarely happens. There are many different metrics to measure the “nearness”, such as Euclidean distance <xref ref-type="bibr" rid="pone.0034460-Chou5">[42]</xref>, Hamming distance <xref ref-type="bibr" rid="pone.0034460-Chou6">[43]</xref>, and Mahalanobis distance <xref ref-type="bibr" rid="pone.0034460-Mahalanobis1">[44]</xref>, <xref ref-type="bibr" rid="pone.0034460-Pillai1">[45]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chou7">[46]</xref>. In the current study, the following equation was adopted to measure the nearness between two samples:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e017" xlink:type="simple"/><label>(5)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e018" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e019" xlink:type="simple"/></inline-formula> are two vectors representing two samples (cf. <bold>Eq. 1</bold>), <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e020" xlink:type="simple"/></inline-formula> is their dot product, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e021" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e022" xlink:type="simple"/></inline-formula> are their moduluses. The smaller the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0034460.e023" xlink:type="simple"/></inline-formula>, the more similar the two samples are. For a concise formulation of the NNA classifier, see Eq. 17 of <xref ref-type="bibr" rid="pone.0034460-Chou1">[16]</xref>; for an intuitive illustration of how the NNA classifier works, see Fig. 5 of <xref ref-type="bibr" rid="pone.0034460-Chou1">[16]</xref>.</p>
      </sec>
      <sec id="s2g">
        <title>Jackknife test</title>
        <p>In statistical prediction, the following three cross-validation methods are often used to examine a predictor for its effectiveness in practical application: independent dataset test, subsampling test, and jackknife test <xref ref-type="bibr" rid="pone.0034460-Chou6">[43]</xref>. However, as illustrated in <xref ref-type="bibr" rid="pone.0034460-Chou8">[47]</xref> and demonstrated by Eq. 50 of <xref ref-type="bibr" rid="pone.0034460-Chou3">[31]</xref>, among the three cross-validation methods, the jackknife test is deemed the least arbitrary that can always yield a unique result for a given benchmark dataset, and hence has been increasingly used by investigators to examine the accuracy of various predictors (see, e.g., <xref ref-type="bibr" rid="pone.0034460-Hu2">[33]</xref>, <xref ref-type="bibr" rid="pone.0034460-Huang1">[34]</xref>, <xref ref-type="bibr" rid="pone.0034460-Huang2">[35]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chou4">[37]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wu1">[38]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wang3">[40]</xref>, <xref ref-type="bibr" rid="pone.0034460-Chou5">[42]</xref>, <xref ref-type="bibr" rid="pone.0034460-Huang3">[48]</xref>, <xref ref-type="bibr" rid="pone.0034460-Hu3">[49]</xref>, <xref ref-type="bibr" rid="pone.0034460-Mohabatkar1">[50]</xref>, <xref ref-type="bibr" rid="pone.0034460-Esmaeili1">[51]</xref>, <xref ref-type="bibr" rid="pone.0034460-Lin1">[52]</xref>, <xref ref-type="bibr" rid="pone.0034460-Nanni1">[53]</xref>, <xref ref-type="bibr" rid="pone.0034460-Xiao3">[54]</xref>, <xref ref-type="bibr" rid="pone.0034460-Wu2">[55]</xref>. Accordingly, in this study, the prediction model was examined by the jackknife test, also known as leave-one-out cross-validation (LOOCV) test. During the course of jackknife test, each sample in the benchmark dataset was in turn singled out as the prediction target and the rest of the samples were used to train the prediction model. The following equation was used to reflect the prediction accuracy:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e024" xlink:type="simple"/><label>(6)</label></disp-formula>where <italic>Y</italic><sub>1</sub>, <italic>Y</italic><sub>2</sub> and <italic>Y</italic><sub>3</sub> represent the numbers of correctly predicted events for the “normal”, “cirrhotic”, and “hepatocellular carcinoma” tissue samples, respectively; while <italic>N</italic><sub>1</sub>, <italic>N</italic><sub>2</sub> and <italic>N</italic><sub>3</sub> stand for the numbers of “normal”, “cirrhotic”, and “hepatocellular carcinoma” samples investigated, respectively.</p>
      </sec>
      <sec id="s2h">
        <title>Incremental feature selection (IFS)</title>
        <p>Based on the ranked features according to their importance evaluated by the mRMR approach, we used Incremental Feature Selection (IFS) <xref ref-type="bibr" rid="pone.0034460-Huang4">[56]</xref>, <xref ref-type="bibr" rid="pone.0034460-He1">[57]</xref> to determine the optimal number of features. During the IFS procedure, features in the ranked feature set were added one by one from higher to lower rank. A new feature set was composed when one feature had been added. Thus <italic>N</italic> feature sets would be composed for the <italic>N</italic> ranked features. The <italic>i</italic>-th feature set is given by<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.e025" xlink:type="simple"/><label>(7)</label></disp-formula>For each of the <italic>N</italic> feature sets, an NNA classifier was constructed and examined using the jackknife test on the benchmark dataset. By doing so we obtained an IFS table with one column for the index <italic>i</italic> and the other columns for the prediction accuracy. Thus, we could obtain the optimal feature set (<italic>S</italic><sub>optimal</sub>), with which the predictor would yield the highest prediction accuracy.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results and Discussion</title>
      <sec id="s3a">
        <title>The IFS results of target genes and between genes</title>
        <p>By analyzing the gene expression profiles for the normal, cirrhotic, and hepatocellular carcinoma liver tissue samples with the mRMR method, we ranked the 290 target genes and 684 between genes according to their importance to liver cirrhosis and hepatocellular carcinoma classification. Subsequently, we selected the optimal gene set from the aforementioned ranked genes by means of the IFS procedure. The IFS curves of the target genes and between genes are shown in <xref ref-type="fig" rid="pone-0034460-g002"><bold>Figure 2</bold></xref>, where the blue curve is the IFS curve for the target genes and the highest accuracy was 0.944 with 155 genes. The red curve is the IFS curve for the between genes and the corresponding highest accuracy was 0.960 with 162 genes. The IFS tables for the target genes and the between genes were given in <bold><xref ref-type="supplementary-material" rid="pone.0034460.s002">Table S1</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0034460.s003">Table S2</xref></bold>, respectively. As shown in <xref ref-type="fig" rid="pone-0034460-g002"><bold>Figure 2</bold></xref>, the accuracies for the between genes were always higher than those for the target genes. The selected 155 target genes and selected 162 between genes can be found in <bold><xref ref-type="supplementary-material" rid="pone.0034460.s004">Table S3</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0034460.s005">Table S4</xref></bold>, respectively. Furthermore, an integrated system containing 916 genes was constructed by combining the set of 290 target genes and the set of 684 between genes. The IFS curve for such 916 target/between genes was shown in <bold><xref ref-type="supplementary-material" rid="pone.0034460.s001">Figure S1</xref></bold>, from which we can see that the corresponding highest accuracy was 0.968 and IFS curve of the combined gen set was twisted with the IFS curve of the between genes, indicating that no significant improvement for the prediction was observed by integrating the target genes with the between genes.</p>
        <fig id="pone-0034460-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0034460.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>The IFS curves of target genes and between genes.</title>
            <p>In the IFS curve, the X-axis is the number of genes used for classification, and the Y-axis is the prediction accuracies of nearest neighbor algorithm evaluated by the jackknife test (or LOOCV). The blue curve is the IFS curve of target genes and the highest accuracy was 0.944 with 155 genes. The red curve is the IFS curve of between genes and the highest accuracy was 0.960 with 162 genes.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.g002" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Analysis of the selected target genes and between genes with HCV</title>
        <p>It is known that HCV is primarily comprised of a single long open-reading-frame encoding an approximately 3000-amino-acid-long protein that is cleaved into three mature structural proteins (CORE, E1, E2), six non-structural proteins (NS2, NS3, NS4A, NS4B, NS5A, NS5B) and a small membrane protein (p7) <xref ref-type="bibr" rid="pone.0034460-Frick1">[58]</xref>, <xref ref-type="bibr" rid="pone.0034460-Cook1">[59]</xref>. To analyze which HCV protein can be related to liver cirrhosis and hepatocellular carcinoma, we calculated the number of the selected target genes for each HCV protein and the number of the selected between genes for each of the HCV protein pairs. Shown in <xref ref-type="fig" rid="pone-0034460-g003"><bold>Figure 3</bold></xref> is the number of selected target genes for each of the HCV proteins. According to <xref ref-type="fig" rid="pone-0034460-g003"><bold>Figure 3</bold></xref>, HCV proteins NS3, NS5A and CORE are the most important ones because they were observed interacting with many target genes in the selected optimal target gene set. The number of the selected between genes for each of the HCV protein pairs is shown in <xref ref-type="fig" rid="pone-0034460-g004"><bold>Figure 4</bold></xref>, from which we can see that the following pairs are involved with more than 80 selected between genes and hence are more important: NS3_NS5A, CORE_NS3, F_NS3, E2_NS3, NS3_NS5B, CORE_NS5A and E1_NS3. Among the above seven pairs, NS3 appeared six times; NS5A, two times; CORE, two times. The outcome is quite similar to that of the target gene. Although there were only 19 genes overlapped between the selected 155 target genes and the selected 162 between genes, the results were quite robust for the HCV protein level. This is because it was found that NS3, NS5A and CORE were important from both the analysis of the selected target genes for each of the HCV proteins and the analysis of the selected between genes for each of the HCV protein pairs. NS3 and NS5A are both non-structural proteins which are responsible for the function of replication and for packaging the viral genome into capsids <xref ref-type="bibr" rid="pone.0034460-Frick1">[58]</xref>. NS3 is a bifunctional protease/helicase <xref ref-type="bibr" rid="pone.0034460-Walker1">[60]</xref>, and is associated with the tumour suppressor p53 <xref ref-type="bibr" rid="pone.0034460-Deng1">[61]</xref>. NS3 has been intensely studied as drug targets <xref ref-type="bibr" rid="pone.0034460-Chen1">[62]</xref>. Although no enzymatic activity has been ascribed to NS5A, it was reported that an inhibitor of HCV NS5A could suppress virus replication in clinical trials <xref ref-type="bibr" rid="pone.0034460-Gao1">[63]</xref>. CORE protein plays an essential role in the formation of virion and it interacts with other HCV proteins <xref ref-type="bibr" rid="pone.0034460-Strosberg1">[64]</xref>, <xref ref-type="bibr" rid="pone.0034460-Mousseau1">[65]</xref>.</p>
        <fig id="pone-0034460-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0034460.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>The number of selected target genes of each HCV protein.</title>
            <p>The HCV proteins NS3, NS5A and CORE have the largest numbers of target genes in the optimal set of the 155 selected target genes.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.g003" xlink:type="simple"/>
        </fig>
        <fig id="pone-0034460-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0034460.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>The number of selected between genes for each of the HCV protein pairs.</title>
            <p>The following pairs have more than 80 selected between genes: NS3_NS5A, CORE_NS3, F_NS3, E2_NS3, NS3_NS5B, CORE_NS5A and E1_NS3.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.g004" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3c">
        <title>Comparison of the selected target genes and between genes with the known hepatocellular carcinoma genes</title>
        <p>To compare the selected target genes and the between genes with the known hepatocellular carcinoma genes, an enrichment analysis was performed for the 155 selected target genes and the 162 selected between genes on the OncoDB.HCC <xref ref-type="bibr" rid="pone.0034460-Su1">[66]</xref> genes. OncoDB.HCC is a comprehensive database of hepatocellular carcinoma related genes <xref ref-type="bibr" rid="pone.0034460-Su1">[66]</xref>. The results thus obtained for the 155 selected target genes and the 162 selected between genes on OncoDB.HCC genes are shown in <xref ref-type="table" rid="pone-0034460-t001"><bold>Table 1</bold></xref>, from which we can see that the 162 selected between genes were significantly (having hypergeometric test p value = 1.25E-05) more enriched with the OncoDB.HCC genes than the 155 selected target genes. Besides, the selected between genes also had greater overlapping with the OncoDB.HCC genes in comparison with the 155 selected target genes.</p>
        <table-wrap id="pone-0034460-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0034460.t001</object-id><label>Table 1</label><caption>
            <title>The enrichment of the 155 selected target genes and the 162 selected between genes on OncoDB.HCC genes.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0034460-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.t001" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Gene Set</td>
                <td align="left" colspan="1" rowspan="1">Hyper geometric test p value</td>
                <td align="left" colspan="1" rowspan="1">Number of overlapped genes with OncoDB.HCC</td>
                <td align="left" colspan="1" rowspan="1">Overlapped genes with OncoDB.HCC</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Selected target genes</td>
                <td align="left" colspan="1" rowspan="1">0.001984</td>
                <td align="left" colspan="1" rowspan="1">15</td>
                <td align="left" colspan="1" rowspan="1">BAX, CD81, CTGF, FAS, GRN, HSPA5, IGLL1, KRT19, NPM1, RAF1, SERPINF2, SERPING1, SRC, THBS1, VIM</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Selected between genes</td>
                <td align="left" colspan="1" rowspan="1">1.25E-05</td>
                <td align="left" colspan="1" rowspan="1">20</td>
                <td align="left" colspan="1" rowspan="1">ALB, AR, CDC20, CDKN2A, COL4A1, CXCL12, DCN, DUSP1, E2F1, ERBB2, GNAS, HSPA5, MAP2K1, MAPRE1, MMP2, MYC, PSMD4, PTK2, ROBO1, SCAMP3</td>
              </tr>
            </tbody>
          </table></alternatives></table-wrap>
      </sec>
      <sec id="s3d">
        <title>The biological meanings of the selected target genes and the between genes</title>
        <p>To reveal the biological meanings, we performed the KEGG enrichment analysis on the 155 selected target genes and the 162 selected between genes using GeneCodis <xref ref-type="bibr" rid="pone.0034460-CarmonaSaez1">[67]</xref>, <xref ref-type="bibr" rid="pone.0034460-NogalesCadenas1">[68]</xref>. Shown in <bold><xref ref-type="supplementary-material" rid="pone.0034460.s006">Table S5</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0034460.s007">Table S6</xref></bold> are the KEGG enrichment results thus obtained for the 155 selected target genes and the 162 selected between genes, respectively. As we can see from the two tables, the 155 selected target genes were enriched on many cancer-related pathways, such as pancreatic cancer, pathways in cancer, chronic myeloid leukemia, colorectal cancer pathways, and other signaling pathways, such as neurotrophin signaling pathway, T cell receptor signaling pathway, B cell receptor signaling pathway, chemokine signaling pathway. Likewise, the 162 selected between genes were also enriched on cancer and signaling pathways, such as pancreatic cancer, chemokine signaling pathway, axon guidance, focal adhesion, and T cell receptor signaling pathway. We also enriched the original 290 target genes and 684 between genes into the KEGG pathways. The selected 155 target genes and selected 162 between genes had more enriched cancer-related pathways and signaling pathways than the original 290 target genes and 684 between genes. Listed in <bold><xref ref-type="supplementary-material" rid="pone.0034460.s008">Table S7</xref></bold> are the numbers of the top 20 enriched KEGG pathways for the 155 selected target genes, the 162 selected between genes, the original 290 target genes, and the original 684 between genes.</p>
        <p>The top five genes in the selected target genes were EFEMP1 (EGF-containing fibulin-like extracellular matrix protein 1), JAG2 (Protein jagged-2), TACSTD2 (Tumor-associated calcium signal transducer 2), STAT3 (Signal transducer and activator of transcription 3) and STAT1 (Signal transducer and activator of transcription 1). EFEMP1 binds EGF receptor and activates downstream signaling pathways. Expression of EFEMP1 promotes angiogenesis and accelerates cancer growth <xref ref-type="bibr" rid="pone.0034460-Song1">[69]</xref>. EFEMP1 is a novel tumor-suppressor gene found in hepatocellular carcinoma <xref ref-type="bibr" rid="pone.0034460-Nomoto1">[70]</xref>. JAG2 is involved in the mediation of Notch signaling and is critical for cell development <xref ref-type="bibr" rid="pone.0034460-Kiernan1">[71]</xref>, <xref ref-type="bibr" rid="pone.0034460-Pietras1">[72]</xref>, <xref ref-type="bibr" rid="pone.0034460-Casey1">[73]</xref>. TACSTD2 encodes a carcinoma-associated antigen and contributes to tumor pathogenesis <xref ref-type="bibr" rid="pone.0034460-Cubas1">[74]</xref>. STAT3 and STAT1 are members of the STAT (Signal Transducers and Activators of Transcription) family of transcription factors that regulates cell differentiation, growth and survival <xref ref-type="bibr" rid="pone.0034460-Wang4">[75]</xref>. In primary tumours, the STAT pathway is usually dysregulated and causes increased angiogenesis, enhanced survival of tumours and immunosuppression <xref ref-type="bibr" rid="pone.0034460-Silva1">[76]</xref>.</p>
        <p>The top five genes in the selected between genes were PDIA3 (Protein disulfide-isomerase A3), LCP2 (Lymphocyte cytosolic protein 2, also known as SLP-76, Src homology 2 domain containing leukocyte protein of 76 kDa), IL23A (Interleukin-23 subunit alpha), SCAMP3 (Secretory carrier-associated membrane protein 3) and ISG15 (Interferon-induced 17 kDa protein). STAT3 ranked sixth in the selected between genes. PDIA3 is part of the MHC (major histocompatibility complex) class I peptide-loading complex, which is vital for the formation of antigen conformation and export from the endoplasmic reticulum (ER) to the cell surface <xref ref-type="bibr" rid="pone.0034460-Garbi1">[77]</xref>. LCP2 plays important roles in promoting T cell development and activation <xref ref-type="bibr" rid="pone.0034460-Shim1">[78]</xref>. IL23A activates the Jak-Stat signaling cascade, induces autoimmune inflammation and may be important for tumorigenesis <xref ref-type="bibr" rid="pone.0034460-Oppmann1">[79]</xref>, <xref ref-type="bibr" rid="pone.0034460-Parham1">[80]</xref>, <xref ref-type="bibr" rid="pone.0034460-Piskin1">[81]</xref>. SCAMP3 can form association with the EGF Receptor <xref ref-type="bibr" rid="pone.0034460-Wu3">[82]</xref>. ISG15 targets to diverse cellular pathways, such as JAK, STAT and MAPK <xref ref-type="bibr" rid="pone.0034460-Zhao1">[83]</xref> and has antiviral activity <xref ref-type="bibr" rid="pone.0034460-Lenschow1">[84]</xref>.</p>
        <p>The KEGG enrichment results for the top five target genes (EFEMP1, JAG2, TACSTD2, STAT3 and STAT1) and for the top five between genes (PDIA3, LCP2, IL23A, SCAMP3, ISG15) are given in <xref ref-type="table" rid="pone-0034460-t002">Table 2</xref>, where it can be seen that STAT1 and STAT3 participated in several well-studied hepatocellular carcinoma pathways, such as Jak-STAT signaling pathway, hepatitis C pathway, and pathways in cancer. Interestingly, both the target genes STAT1/STAT3 and the between gene IL23A were involved in Jak-STAT signaling pathway; the latter is associated with HCV clinical syndromes <xref ref-type="bibr" rid="pone.0034460-deChassey1">[22]</xref>, <xref ref-type="bibr" rid="pone.0034460-RomeroGomez1">[85]</xref>.</p>
        <table-wrap id="pone-0034460-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0034460.t002</object-id><label>Table 2</label><caption>
            <title>The KEGG enrichment of the top five target genes (EFEMP1, JAG2, TACSTD2, STAT3 and STAT1) and the top five between genes (PDIA3, LCP2, IL23A, SCAMP3, ISG15).</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0034460-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.t002" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">KEGG</td>
                <td align="left" colspan="1" rowspan="1">Corrected hyper geometric p value</td>
                <td align="left" colspan="1" rowspan="1">Genes</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">04630 :Jak-STAT signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.000327</td>
                <td align="left" colspan="1" rowspan="1">STAT1,IL23A,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05212 :Pancreatic cancer</td>
                <td align="left" colspan="1" rowspan="1">0.002516</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05160 :Hepatitis C</td>
                <td align="left" colspan="1" rowspan="1">0.003061</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05162 :Measles</td>
                <td align="left" colspan="1" rowspan="1">0.003619</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05145 :Toxoplasmosis</td>
                <td align="left" colspan="1" rowspan="1">0.00439</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04062 :Chemokine signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.004439</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05152 :Tuberculosis</td>
                <td align="left" colspan="1" rowspan="1">0.004603</td>
                <td align="left" colspan="1" rowspan="1">STAT1,IL23A</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04380 :Osteoclast differentiation</td>
                <td align="left" colspan="1" rowspan="1">0.005503</td>
                <td align="left" colspan="1" rowspan="1">LCP2,STAT1</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05200 :Pathways in cancer</td>
                <td align="left" colspan="1" rowspan="1">0.011662</td>
                <td align="left" colspan="1" rowspan="1">STAT1,STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04330 :Notch signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.033518</td>
                <td align="left" colspan="1" rowspan="1">JAG2</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05140 :Leishmaniasis</td>
                <td align="left" colspan="1" rowspan="1">0.034105</td>
                <td align="left" colspan="1" rowspan="1">STAT1</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04664 :Fc epsilon RI signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.034608</td>
                <td align="left" colspan="1" rowspan="1">LCP2</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04622 :RIG-I-like receptor signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.036039</td>
                <td align="left" colspan="1" rowspan="1">ISG15</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05221 :Acute myeloid leukemia</td>
                <td align="left" colspan="1" rowspan="1">0.036899</td>
                <td align="left" colspan="1" rowspan="1">STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">05323 :Rheumatoid arthritis</td>
                <td align="left" colspan="1" rowspan="1">0.037517</td>
                <td align="left" colspan="1" rowspan="1">IL23A</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04612 :Antigen processing and presentation</td>
                <td align="left" colspan="1" rowspan="1">0.03827</td>
                <td align="left" colspan="1" rowspan="1">PDIA3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04620 :Toll-like receptor signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.040087</td>
                <td align="left" colspan="1" rowspan="1">STAT1</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04660 :T cell receptor signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.040175</td>
                <td align="left" colspan="1" rowspan="1">LCP2</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04920 :Adipocytokine signaling pathway</td>
                <td align="left" colspan="1" rowspan="1">0.040873</td>
                <td align="left" colspan="1" rowspan="1">STAT3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">04650 :Natural killer cell mediated cytotoxicity</td>
                <td align="left" colspan="1" rowspan="1">0.045794</td>
                <td align="left" colspan="1" rowspan="1">LCP2</td>
              </tr>
            </tbody>
          </table></alternatives></table-wrap>
      </sec>
      <sec id="s3e">
        <title>The advantages of between genes as biomarkers and drug targets</title>
        <p>The between genes are not only the coordinator of HCV that triggers the disease-causing signaling, but also the carrier that executes such order and actually causes the pathological changes. Among the top five between genes, ISG15 was on the shortest path of 289 HCV target gene pairs. It regulates and functions in diverse cancer-related pathways <xref ref-type="bibr" rid="pone.0034460-Zhao1">[83]</xref>. It has been identified as an antiviral molecule <xref ref-type="bibr" rid="pone.0034460-Lenschow1">[84]</xref>. As the bridge of HCV infection, the between genes are responsible for the initiation and progression of hepatocellular cirrhosis and carcinoma. They have closer relationship with the pathological changes during the transformation of hepatocellular cirrhosis and carcinoma than HCV proteins or their target genes. The target genes may indicate the early response of HCV infection, but the between genes can more accurately reflect the post-infection pathological processes and hence be used to serve as a better biomarker. The classification accuracy of the 162 selected between genes was 0.960, higher the accuracy of the 155 selected target genes, 0.944. The accuracy of the top five between genes was 0.815, also higher the accuracy of the top five target genes, 0.782. Classifier based on the between genes performed better than the classifier based on the target genes. Since the between genes play important roles in the course of both initiating the disease and its aggravation, they may become a drug target for both the preventive and therapeutic purposes, like the between gene ISG15 already did <xref ref-type="bibr" rid="pone.0034460-Lenschow1">[84]</xref>.</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Supporting Information</title>
      <supplementary-material id="pone.0034460.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>The IFS curve of the combined gene set. (A) The IFS curve of the combined gene set, between genes and target genes. The black, red and blue lines represent the IFS curve of the combined gene set, between genes and target genes, respectively. The curve of between genes is consistently higher than the curve of target genes. The curve of combined gene set is twisted with the curve of between genes. (B) The top ten gene IFS curve of the combined gene set, between genes and target genes. The black, red and blue lines represent the IFS curve of the combined gene set, between genes and target genes, respectively. Within the top ten genes, the highest accuracy of between genes is greater than the accuracies of combined gene set and target genes.</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s002" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s002" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>The IFS table of the target genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s003" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s003" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <p>The IFS table of the between genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s004" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s004" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <p>The selected 155 target genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s005" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s005" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <p>The selected 162 between genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s006" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s006" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <p>The KEGG enrichment result of the 155 selected target genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s007" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s007" xlink:type="simple">
        <label>Table S6</label>
        <caption>
          <p>The KEGG enrichment result of the 162 selected between genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0034460.s008" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0034460.s008" xlink:type="simple">
        <label>Table S7</label>
        <caption>
          <p>The top 20 enriched KEGG pathways for the 155 selected target genes, the 162 selected between genes, the original 290 target genes, and the 684 original between genes.</p>
          <p>(XLSX)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors wish to thank the editor and two anonymous reviewers for their constructive comments, which were very helpful for strengthening the presentation of this paper. The authors thank members of the Cell and Tissue Engineering Laboratory at the National University Health System for scientific discussions.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0034460-Tsukuma1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tsukuma</surname><given-names>H</given-names></name><name name-style="western"><surname>Hiyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakao</surname><given-names>M</given-names></name><name name-style="western"><surname>Yabuuchi</surname><given-names>T</given-names></name><etal/></person-group>             <year>1993</year>             <article-title>Risk factors for hepatocellular carcinoma among patients with chronic liver disease.</article-title>             <source>N Engl J Med</source>             <volume>328</volume>             <fpage>1797</fpage>             <lpage>1801</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-ElSerag1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>El-Serag</surname><given-names>HB</given-names></name><name name-style="western"><surname>Mason</surname><given-names>AC</given-names></name></person-group>             <year>1999</year>             <article-title>Rising incidence of hepatocellular carcinoma in the United States.</article-title>             <source>N Engl J Med</source>             <volume>340</volume>             <fpage>745</fpage>             <lpage>750</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Tagger1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tagger</surname><given-names>A</given-names></name><name name-style="western"><surname>Donato</surname><given-names>F</given-names></name><name name-style="western"><surname>Ribero</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chiesa</surname><given-names>R</given-names></name><name name-style="western"><surname>Portera</surname><given-names>G</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.</article-title>             <source>Int J Cancer</source>             <volume>81</volume>             <fpage>695</fpage>             <lpage>699</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Farazi1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Farazi</surname><given-names>PA</given-names></name><name name-style="western"><surname>DePinho</surname><given-names>RA</given-names></name></person-group>             <year>2006</year>             <article-title>Hepatocellular carcinoma pathogenesis: from genes to environment.</article-title>             <source>Nat Rev Cancer</source>             <volume>6</volume>             <fpage>674</fpage>             <lpage>687</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-DeGiorgi1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>De Giorgi</surname><given-names>V</given-names></name><name name-style="western"><surname>Monaco</surname><given-names>A</given-names></name><name name-style="western"><surname>Worchech</surname><given-names>A</given-names></name><name name-style="western"><surname>Tornesello</surname><given-names>M</given-names></name><name name-style="western"><surname>Izzo</surname><given-names>F</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.</article-title>             <source>Journal of translational medicine</source>             <volume>7</volume>             <fpage>85</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-ElSerag2">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>El-Serag</surname><given-names>HB</given-names></name><name name-style="western"><surname>Marrero</surname><given-names>JA</given-names></name><name name-style="western"><surname>Rudolph</surname><given-names>L</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>KR</given-names></name></person-group>             <year>2008</year>             <article-title>Diagnosis and treatment of hepatocellular carcinoma.</article-title>             <source>Gastroenterology</source>             <volume>134</volume>             <fpage>1752</fpage>             <lpage>1763</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Hoshida1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hoshida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Villanueva</surname><given-names>A</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Peix</surname><given-names>J</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>DY</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Gene expression in fixed tissues and outcome in hepatocellular carcinoma.</article-title>             <source>N Engl J Med</source>             <volume>359</volume>             <fpage>1995</fpage>             <lpage>2004</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Shang1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>S</given-names></name><name name-style="western"><surname>Plymoth</surname><given-names>A</given-names></name><name name-style="western"><surname>Ge</surname><given-names>S</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>HR</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Identification of osteopontin as a novel marker for early hepatocellular carcinoma.</article-title>             <source>Hepatology</source>          </element-citation>
      </ref>
      <ref id="pone.0034460-Zhang1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name></person-group>             <year>2011</year>             <article-title>Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique.</article-title>             <source>J Clin Lab Anal</source>             <volume>25</volume>             <fpage>402</fpage>             <lpage>408</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Kudo1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kudo</surname><given-names>M</given-names></name></person-group>             <year>2011</year>             <article-title>Future treatment option for hepatocellular carcinoma: a focus on brivanib.</article-title>             <source>Dig Dis</source>             <volume>29</volume>             <fpage>316</fpage>             <lpage>320</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Lemmer1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lemmer</surname><given-names>ER</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>SL</given-names></name><name name-style="western"><surname>Llovet</surname><given-names>JM</given-names></name></person-group>             <year>2006</year>             <article-title>Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.</article-title>             <source>Seminars in liver disease</source>             <volume>26</volume>             <fpage>373</fpage>             <lpage>384</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wang1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>PW</given-names></name><name name-style="western"><surname>Salem</surname><given-names>N</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tennant</surname><given-names>BC</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results.</article-title>             <source>International journal of oncology</source>             <volume>30</volume>             <fpage>33</fpage>             <lpage>44</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Zhang2">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>LH</given-names></name><name name-style="western"><surname>Ji</surname><given-names>JF</given-names></name></person-group>             <year>2005</year>             <article-title>Molecular profiling of hepatocellular carcinomas by cDNA microarray.</article-title>             <source>World journal of gastroenterology : WJG</source>             <volume>11</volume>             <fpage>463</fpage>             <lpage>468</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Michiels1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Michiels</surname><given-names>S</given-names></name><name name-style="western"><surname>Koscielny</surname><given-names>S</given-names></name><name name-style="western"><surname>Hill</surname><given-names>C</given-names></name></person-group>             <year>2005</year>             <article-title>Prediction of cancer outcome with microarrays: a multiple random validation strategy.</article-title>             <source>Lancet</source>             <volume>365</volume>             <fpage>488</fpage>             <lpage>492</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Abraham1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>G</given-names></name><name name-style="western"><surname>Kowalczyk</surname><given-names>A</given-names></name><name name-style="western"><surname>Loi</surname><given-names>S</given-names></name><name name-style="western"><surname>Haviv</surname><given-names>I</given-names></name><name name-style="western"><surname>Zobel</surname><given-names>J</given-names></name></person-group>             <year>2010</year>             <article-title>Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context.</article-title>             <source>BMC Bioinformatics</source>             <volume>11</volume>             <fpage>277</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>Some remarks on protein attribute prediction and pseudo amino acid composition (50th Anniversary Year Review).</article-title>             <source>Journal of Theoretical Biology</source>             <volume>273</volume>             <fpage>236</fpage>             <lpage>247</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Mas1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mas</surname><given-names>VR</given-names></name><name name-style="western"><surname>Maluf</surname><given-names>DG</given-names></name><name name-style="western"><surname>Archer</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Yanek</surname><given-names>K</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.</article-title>             <source>Mol Med</source>             <volume>15</volume>             <fpage>85</fpage>             <lpage>94</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Huber1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>W</given-names></name><name name-style="western"><surname>Gentleman</surname><given-names>R</given-names></name></person-group>             <year>2004</year>             <article-title>matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements.</article-title>             <source>Bioinformatics</source>             <volume>20</volume>             <fpage>1651</fpage>             <lpage>1652</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Irizarry1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Irizarry</surname><given-names>RA</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>B</given-names></name><name name-style="western"><surname>Collin</surname><given-names>F</given-names></name><name name-style="western"><surname>Beazer-Barclay</surname><given-names>YD</given-names></name><name name-style="western"><surname>Antonellis</surname><given-names>KJ</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Exploration, normalization, and summaries of high density oligonucleotide array probe level data.</article-title>             <source>Biostatistics</source>             <volume>4</volume>             <fpage>249</fpage>             <lpage>264</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Bolstad1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bolstad</surname><given-names>BM</given-names></name><name name-style="western"><surname>Irizarry</surname><given-names>RA</given-names></name><name name-style="western"><surname>Astrand</surname><given-names>M</given-names></name><name name-style="western"><surname>Speed</surname><given-names>TP</given-names></name></person-group>             <year>2003</year>             <article-title>A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.</article-title>             <source>Bioinformatics</source>             <volume>19</volume>             <fpage>185</fpage>             <lpage>193</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou2">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2009</year>             <article-title>Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology.</article-title>             <source>Current Proteomics</source>             <volume>6</volume>             <fpage>262</fpage>             <lpage>274</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-deChassey1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>de Chassey</surname><given-names>B</given-names></name><name name-style="western"><surname>Navratil</surname><given-names>V</given-names></name><name name-style="western"><surname>Tafforeau</surname><given-names>L</given-names></name><name name-style="western"><surname>Hiet</surname><given-names>MS</given-names></name><name name-style="western"><surname>Aublin-Gex</surname><given-names>A</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Hepatitis C virus infection protein network.</article-title>             <source>Mol Syst Biol</source>             <volume>4</volume>             <fpage>230</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Jensen1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>M</given-names></name><name name-style="western"><surname>Stark</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaffron</surname><given-names>S</given-names></name><name name-style="western"><surname>Creevey</surname><given-names>C</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>STRING 8–a global view on proteins and their functional interactions in 630 organisms.</article-title>             <source>Nucleic Acids Res</source>             <volume>37</volume>             <fpage>D412</fpage>             <lpage>416</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Dijkstra1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dijkstra</surname><given-names>EW</given-names></name></person-group>             <year>1959</year>             <article-title>A note on two problems in connexion with graphs.</article-title>             <source>Numerische Mathematik</source>             <volume>1</volume>             <fpage>269</fpage>             <lpage>271</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chartrand1">
        <label>25</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chartrand</surname><given-names>G</given-names></name><name name-style="western"><surname>Oellermann</surname><given-names>OR</given-names></name></person-group>             <year>1992</year>             <comment>Applied and Algorithmic Graph Theory: Mcgraw-Hill College</comment>          </element-citation>
      </ref>
      <ref id="pone.0034460-Cormen1">
        <label>26</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cormen</surname><given-names>TH</given-names></name><name name-style="western"><surname>Leiserson</surname><given-names>CE</given-names></name><name name-style="western"><surname>R.L.</surname><given-names>R</given-names></name><name name-style="western"><surname>Stein</surname><given-names>C</given-names></name></person-group>             <year>2001</year>             <comment>Introduction to Algorithms (second ed.): MIT press and Mcgraw-Hill</comment>          </element-citation>
      </ref>
      <ref id="pone.0034460-Peng1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>H</given-names></name><name name-style="western"><surname>Long</surname><given-names>F</given-names></name><name name-style="western"><surname>Ding</surname><given-names>C</given-names></name></person-group>             <year>2005</year>             <article-title>Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.</article-title>             <source>IEEE Trans Pattern Anal Mach Intell</source>             <volume>27</volume>             <fpage>1226</fpage>             <lpage>1238</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Cover1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cover</surname><given-names>TM</given-names></name><name name-style="western"><surname>Hart</surname><given-names>PE</given-names></name></person-group>             <year>1967</year>             <article-title>Nearest Neighbor Pattern Classification.</article-title>             <source>Ieee Transactions on Information Theory</source>             <volume>13</volume>             <fpage>21</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Friedman1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>JH</given-names></name><name name-style="western"><surname>Baskett</surname><given-names>F</given-names></name><name name-style="western"><surname>Shustek</surname><given-names>LJ</given-names></name></person-group>             <year>1975</year>             <article-title>An algorithm for finding nearest neighbors.</article-title>             <source>IEEE Transaction on Information Theory</source>             <volume>C-24</volume>             <fpage>1000</fpage>             <lpage>1006</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Denoeux1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Denoeux</surname><given-names>T</given-names></name></person-group>             <year>1995</year>             <article-title>A k-nearest neighbor classification rule based on Dempster-Shafer theory.</article-title>             <source>IEEE Transactions on Systems, Man and Cybernetics</source>             <volume>25</volume>             <fpage>804</fpage>             <lpage>813</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou3">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name><name name-style="western"><surname>Shen</surname><given-names>HB</given-names></name></person-group>             <year>2007</year>             <article-title>Review: Recent progresses in protein subcellular location prediction.</article-title>             <source>Analytical Biochemistry</source>             <volume>370</volume>             <fpage>1</fpage>             <lpage>16</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Hu1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>WC</given-names></name><name name-style="western"><surname>Cai</surname><given-names>YD</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Predicting functions of proteins in mouse based on weighted protein-protein interaction network and protein hybrid properties</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e14556</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Hu2">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>LL</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Cai</surname><given-names>YD</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network.</article-title>             <source>PLoS One</source>             <volume>6</volume>             <fpage>e22989</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Huang1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Cai</surname><given-names>YD</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>Classification and analysis of regulatory pathways using graph property, biochemical and physicochemical property, and functional property.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e25297</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Huang2">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Niu</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Predicting Transcriptional Activity of Multiple Site p53 Mutants Based on Hybrid Properties.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e22940</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wang2">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Prediction of antimicrobial peptides based on sequence alignment and feature selection methods.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e18476</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou4">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name></person-group>             <year>2012</year>             <article-title>iLoc-Hum: Using accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites.</article-title>             <source>Molecular Biosystems</source>             <volume>8</volume>             <fpage>629</fpage>             <lpage>641</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wu1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2012</year>             <article-title>iLoc-Gpos: A Multi-Layer Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Gram-Positive Bacterial Proteins.</article-title>             <source>Protein &amp; Peptide Letters</source>             <volume>19</volume>             <fpage>4</fpage>             <lpage>14</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Xiao1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>GPCR-2L: Predicting G protein-coupled receptors and their types by hybridizing two different modes of pseudo amino acid compositions.</article-title>             <source>Molecular Biosystems</source>             <volume>7</volume>             <fpage>911</fpage>             <lpage>919</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wang3">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>NR-2L: A Two-Level Predictor for Identifying Nuclear Receptor Subfamilies Based on Sequence-Derived Features.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e23505</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Xiao2">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>A multi-label classifier for predicting the subcellular localization of gram-negative bacterial proteins with both single and multiple sites.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e20592</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou5">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name></person-group>             <year>2011</year>             <article-title>iLoc-Euk: A Multi-Label Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Eukaryotic Proteins.</article-title>             <source>PLoS One</source>             <volume>6</volume>             <fpage>e18258</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou6">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CT</given-names></name></person-group>             <year>1995</year>             <article-title>Review: Prediction of protein structural classes.</article-title>             <source>Critical Reviews in Biochemistry and Molecular Biology</source>             <volume>30</volume>             <fpage>275</fpage>             <lpage>349</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Mahalanobis1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mahalanobis</surname><given-names>PC</given-names></name></person-group>             <year>1936</year>             <article-title>On the generalized distance in statistics.</article-title>             <source>Proc Natl Inst Sci India</source>             <volume>2</volume>             <fpage>49</fpage>             <lpage>55</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Pillai1">
        <label>45</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pillai</surname><given-names>KCS</given-names></name></person-group>             <year>1985</year>             <article-title>Mahalanobis D2.</article-title>             <person-group person-group-type="editor"><name name-style="western"><surname>Kotz</surname><given-names>S</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>NL</given-names></name></person-group>             <source>Encyclopedia of Statistical Sciences</source>             <publisher-loc>New York</publisher-loc>             <publisher-name>John Wiley &amp; Sons</publisher-name>             <fpage>176</fpage>             <lpage>181</lpage>             <comment>This reference also presents a brief biography of Mahalanobis who was a man of great originality and who made considerable contributions to statistics</comment>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou7">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>1995</year>             <article-title>A novel approach to predicting protein structural classes in a (20-1)-D amino acid composition space.</article-title>             <source>Proteins: Structure, Function &amp; Genetics</source>             <volume>21</volume>             <fpage>319</fpage>             <lpage>344</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chou8">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name><name name-style="western"><surname>Shen</surname><given-names>HB</given-names></name></person-group>             <year>2008</year>             <article-title>Cell-PLoc: A package of Web servers for predicting subcellular localization of proteins in various organisms (updated version: Cell-PLoc 2.0: An improved package of web-servers for predicting subcellular localization of proteins in various organisms, Natural Science, 2010, 2, 1090–1103).</article-title>             <source>Nature Protocols</source>             <volume>3</volume>             <fpage>153</fpage>             <lpage>162</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Huang3">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>XH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Feng</surname><given-names>KY</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks.</article-title>             <source>PLoS ONE</source>             <volume>5</volume>             <fpage>e10972</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Hu3">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>LL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Cai</surname><given-names>YD</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>Predicting biological functions of compounds based on chemical-chemical interactions.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e29491</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Mohabatkar1">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mohabatkar</surname><given-names>H</given-names></name><name name-style="western"><surname>Mohammad Beigi</surname><given-names>M</given-names></name><name name-style="western"><surname>Esmaeili</surname><given-names>A</given-names></name></person-group>             <year>2011</year>             <article-title>Prediction of GABA(A) receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine.</article-title>             <source>Journal of Theoretical Biology</source>             <volume>281</volume>             <fpage>18</fpage>             <lpage>23</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Esmaeili1">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Esmaeili</surname><given-names>M</given-names></name><name name-style="western"><surname>Mohabatkar</surname><given-names>H</given-names></name><name name-style="western"><surname>Mohsenzadeh</surname><given-names>S</given-names></name></person-group>             <year>2010</year>             <article-title>Using the concept of Chou's pseudo amino acid composition for risk type prediction of human papillomaviruses.</article-title>             <source>Journal of Theoretical Biology</source>             <volume>263</volume>             <fpage>203</fpage>             <lpage>209</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Lin1">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>WZ</given-names></name><name name-style="western"><surname>Fang</surname><given-names>JA</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>iDNA-Prot: Identification of DNA Binding Proteins Using Random Forest with Grey Model.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e24756</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Nanni1">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nanni</surname><given-names>L</given-names></name><name name-style="western"><surname>Lumini</surname><given-names>A</given-names></name></person-group>             <year>2009</year>             <article-title>A Further Step Toward an Optimal Ensemble of Classifiers for Peptide Classification, a Case Study: HIV Protease.</article-title>             <source>Protein &amp; Peptide Letters</source>             <volume>16</volume>             <fpage>163</fpage>             <lpage>167</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Xiao3">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>iLoc-Virus: A multi-label learning classifier for identifying the subcellular localization of virus proteins with both single and multiple sites.</article-title>             <source>Journal of Theoretical Biology</source>             <volume>284</volume>             <fpage>42</fpage>             <lpage>51</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wu2">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>ZC</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KC</given-names></name></person-group>             <year>2011</year>             <article-title>iLoc-Plant: a multi-label classifier for predicting the subcellular localization of plant proteins with both single and multiple sites.</article-title>             <source>Molecular BioSystems</source>             <volume>7</volume>             <fpage>3287</fpage>             <lpage>3297</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Huang4">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Cui</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Feng</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>YX</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles.</article-title>             <source>PLoS One</source>             <volume>4</volume>             <fpage>e8126</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-He1">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Shi</surname><given-names>XH</given-names></name><name name-style="western"><surname>Hu</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Predicting drug-target interaction networks based on functional groups and biological features.</article-title>             <source>PLoS ONE</source>             <volume>5</volume>             <fpage>e9603</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Frick1">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Frick</surname><given-names>DN</given-names></name></person-group>             <year>2007</year>             <article-title>The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.</article-title>             <source>Curr Issues Mol Biol</source>             <volume>9</volume>             <fpage>1</fpage>             <lpage>20</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Cook1">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>GA</given-names></name><name name-style="western"><surname>Stefer</surname><given-names>S</given-names></name><name name-style="western"><surname>Opella</surname><given-names>SJ</given-names></name></person-group>             <year>2011</year>             <article-title>Expression and purification of the membrane protein p7 from hepatitis C virus.</article-title>             <source>Biopolymers</source>             <volume>96</volume>             <fpage>32</fpage>             <lpage>40</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Walker1">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>MP</given-names></name><name name-style="western"><surname>Appleby</surname><given-names>TC</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>W</given-names></name><name name-style="western"><surname>Lau</surname><given-names>JY</given-names></name><name name-style="western"><surname>Hong</surname><given-names>Z</given-names></name></person-group>             <year>2003</year>             <article-title>Hepatitis C virus therapies: current treatments, targets and future perspectives.</article-title>             <source>Antivir Chem Chemother</source>             <volume>14</volume>             <fpage>1</fpage>             <lpage>21</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Deng1">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>L</given-names></name><name name-style="western"><surname>Nagano-Fujii</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Nomura-Takigawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>M</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner.</article-title>             <source>J Gen Virol</source>             <volume>87</volume>             <fpage>1703</fpage>             <lpage>1713</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Chen1">
        <label>62</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Tan</surname><given-names>SL</given-names></name></person-group>             <year>2005</year>             <article-title>Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.</article-title>             <source>Curr Med Chem</source>             <volume>12</volume>             <fpage>2317</fpage>             <lpage>2342</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Gao1">
        <label>63</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>M</given-names></name><name name-style="western"><surname>Nettles</surname><given-names>RE</given-names></name><name name-style="western"><surname>Belema</surname><given-names>M</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>LB</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>VN</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.</article-title>             <source>Nature</source>             <volume>465</volume>             <fpage>96</fpage>             <lpage>100</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Strosberg1">
        <label>64</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Strosberg</surname><given-names>AD</given-names></name><name name-style="western"><surname>Kota</surname><given-names>S</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>V</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>JK</given-names></name><name name-style="western"><surname>Mousseau</surname><given-names>G</given-names></name></person-group>             <year>2010</year>             <article-title>Core as a Novel Viral Target for Hepatitis C Drugs.</article-title>             <source>Viruses</source>             <volume>2</volume>             <fpage>1734</fpage>             <lpage>1751</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Mousseau1">
        <label>65</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mousseau</surname><given-names>G</given-names></name><name name-style="western"><surname>Kota</surname><given-names>S</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>V</given-names></name><name name-style="western"><surname>Frick</surname><given-names>DN</given-names></name><name name-style="western"><surname>Strosberg</surname><given-names>AD</given-names></name></person-group>             <year>2011</year>             <article-title>Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase.</article-title>             <source>J Gen Virol</source>             <volume>92</volume>             <fpage>101</fpage>             <lpage>111</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Su1">
        <label>66</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>WH</given-names></name><name name-style="western"><surname>Chao</surname><given-names>CC</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>DS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>PJ</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.</article-title>             <source>Nucleic Acids Res</source>             <volume>35</volume>             <fpage>D727</fpage>             <lpage>731</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-CarmonaSaez1">
        <label>67</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Carmona-Saez</surname><given-names>P</given-names></name><name name-style="western"><surname>Chagoyen</surname><given-names>M</given-names></name><name name-style="western"><surname>Tirado</surname><given-names>F</given-names></name><name name-style="western"><surname>Carazo</surname><given-names>JM</given-names></name><name name-style="western"><surname>Pascual-Montano</surname><given-names>A</given-names></name></person-group>             <year>2007</year>             <article-title>GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists.</article-title>             <source>Genome Biol</source>             <volume>8</volume>             <fpage>R3</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-NogalesCadenas1">
        <label>68</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nogales-Cadenas</surname><given-names>R</given-names></name><name name-style="western"><surname>Carmona-Saez</surname><given-names>P</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>M</given-names></name><name name-style="western"><surname>Vicente</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information.</article-title>             <source>Nucleic Acids Res</source>             <volume>37</volume>             <fpage>W317</fpage>             <lpage>322</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Song1">
        <label>69</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>EL</given-names></name><name name-style="western"><surname>Hou</surname><given-names>YP</given-names></name><name name-style="western"><surname>Yu</surname><given-names>SP</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SG</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JT</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo.</article-title>             <source>Gynecol Oncol</source>             <volume>121</volume>             <fpage>174</fpage>             <lpage>180</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Nomoto1">
        <label>70</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nomoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Kanda</surname><given-names>M</given-names></name><name name-style="western"><surname>Okamura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nishikawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiyong</surname><given-names>L</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.</article-title>             <source>Ann Surg Oncol</source>             <volume>17</volume>             <fpage>923</fpage>             <lpage>932</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Kiernan1">
        <label>71</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kiernan</surname><given-names>AE</given-names></name><name name-style="western"><surname>Cordes</surname><given-names>R</given-names></name><name name-style="western"><surname>Kopan</surname><given-names>R</given-names></name><name name-style="western"><surname>Gossler</surname><given-names>A</given-names></name><name name-style="western"><surname>Gridley</surname><given-names>T</given-names></name></person-group>             <year>2005</year>             <article-title>The Notch ligands DLL1 and JAG2 act synergistically to regulate hair cell development in the mammalian inner ear.</article-title>             <source>Development</source>             <volume>132</volume>             <fpage>4353</fpage>             <lpage>4362</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Pietras1">
        <label>72</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pietras</surname><given-names>A</given-names></name><name name-style="western"><surname>von Stedingk</surname><given-names>K</given-names></name><name name-style="western"><surname>Lindgren</surname><given-names>D</given-names></name><name name-style="western"><surname>Pahlman</surname><given-names>S</given-names></name><name name-style="western"><surname>Axelson</surname><given-names>H</given-names></name></person-group>             <year>2011</year>             <article-title>JAG2 Induction in Hypoxic Tumor Cells Alters Notch Signaling and Enhances Endothelial Cell Tube Formation.</article-title>             <source>Mol Cancer Res</source>             <volume>9</volume>             <fpage>626</fpage>             <lpage>636</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Casey1">
        <label>73</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Casey</surname><given-names>LM</given-names></name><name name-style="western"><surname>Lan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cho</surname><given-names>ES</given-names></name><name name-style="western"><surname>Maltby</surname><given-names>KM</given-names></name><name name-style="western"><surname>Gridley</surname><given-names>T</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development.</article-title>             <source>Dev Dyn</source>             <volume>235</volume>             <fpage>1830</fpage>             <lpage>1844</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Cubas1">
        <label>74</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cubas</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Q</given-names></name></person-group>             <year>2010</year>             <article-title>Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.</article-title>             <source>Mol Cancer</source>             <volume>9</volume>             <fpage>253</fpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wang4">
        <label>75</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>YH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>ML</given-names></name></person-group>             <year>2010</year>             <article-title>Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.</article-title>             <source>Dev Dyn</source>             <volume>239</volume>             <fpage>2522</fpage>             <lpage>2533</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Silva1">
        <label>76</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>CM</given-names></name></person-group>             <year>2004</year>             <article-title>Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.</article-title>             <source>Oncogene</source>             <volume>23</volume>             <fpage>8017</fpage>             <lpage>8023</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Garbi1">
        <label>77</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Garbi</surname><given-names>N</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Momburg</surname><given-names>F</given-names></name><name name-style="western"><surname>Hammerling</surname><given-names>GJ</given-names></name></person-group>             <year>2006</year>             <article-title>Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57.</article-title>             <source>Nat Immunol</source>             <volume>7</volume>             <fpage>93</fpage>             <lpage>102</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Shim1">
        <label>78</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shim</surname><given-names>EK</given-names></name><name name-style="western"><surname>Jung</surname><given-names>SH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JR</given-names></name></person-group>             <year>2011</year>             <article-title>Role of two adaptor molecules SLP-76 and LAT in the PI3K signaling pathway in activated T cells.</article-title>             <source>J Immunol</source>             <volume>186</volume>             <fpage>2926</fpage>             <lpage>2935</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Oppmann1">
        <label>79</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Oppmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Lesley</surname><given-names>R</given-names></name><name name-style="western"><surname>Blom</surname><given-names>B</given-names></name><name name-style="western"><surname>Timans</surname><given-names>JC</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.</article-title>             <source>Immunity</source>             <volume>13</volume>             <fpage>715</fpage>             <lpage>725</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Parham1">
        <label>80</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Parham</surname><given-names>C</given-names></name><name name-style="western"><surname>Chirica</surname><given-names>M</given-names></name><name name-style="western"><surname>Timans</surname><given-names>J</given-names></name><name name-style="western"><surname>Vaisberg</surname><given-names>E</given-names></name><name name-style="western"><surname>Travis</surname><given-names>M</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.</article-title>             <source>J Immunol</source>             <volume>168</volume>             <fpage>5699</fpage>             <lpage>5708</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Piskin1">
        <label>81</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Piskin</surname><given-names>G</given-names></name><name name-style="western"><surname>Sylva-Steenland</surname><given-names>RM</given-names></name><name name-style="western"><surname>Bos</surname><given-names>JD</given-names></name><name name-style="western"><surname>Teunissen</surname><given-names>MB</given-names></name></person-group>             <year>2006</year>             <article-title>In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.</article-title>             <source>J Immunol</source>             <volume>176</volume>             <fpage>1908</fpage>             <lpage>1915</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Wu3">
        <label>82</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>TT</given-names></name><name name-style="western"><surname>Castle</surname><given-names>JD</given-names></name></person-group>             <year>1998</year>             <article-title>Tyrosine phosphorylation of selected secretory carrier membrane proteins, SCAMP1 and SCAMP3, and association with the EGF receptor.</article-title>             <source>Mol Biol Cell</source>             <volume>9</volume>             <fpage>1661</fpage>             <lpage>1674</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Zhao1">
        <label>83</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name><name name-style="western"><surname>Denison</surname><given-names>C</given-names></name><name name-style="western"><surname>Huibregtse</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gygi</surname><given-names>S</given-names></name><name name-style="western"><surname>Krug</surname><given-names>RM</given-names></name></person-group>             <year>2005</year>             <article-title>Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>102</volume>             <fpage>10200</fpage>             <lpage>10205</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-Lenschow1">
        <label>84</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lenschow</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Giannakopoulos</surname><given-names>NV</given-names></name><name name-style="western"><surname>Gunn</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>C</given-names></name><name name-style="western"><surname>O'Guin</surname><given-names>AK</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo.</article-title>             <source>J Virol</source>             <volume>79</volume>             <fpage>13974</fpage>             <lpage>13983</lpage>          </element-citation>
      </ref>
      <ref id="pone.0034460-RomeroGomez1">
        <label>85</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Romero-Gomez</surname><given-names>M</given-names></name></person-group>             <year>2006</year>             <article-title>Insulin resistance and hepatitis C.</article-title>             <source>World J Gastroenterol</source>             <volume>12</volume>             <fpage>7075</fpage>             <lpage>7080</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>